VYNE Therapeutics CEO Steven Basta's 2019 pay falls 28% to $1.9M
VYNE Therapeutics reports 2019 executive compensation
By ExecPay News
Published: June 22, 2020
VYNE Therapeutics reported fiscal year 2019 executive compensation information on June 22, 2020.
In 2019, three executives at VYNE Therapeutics received on average a compensation package of $1.2M, a 30% decrease compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
Steven Basta, Chief Executive Officer, received $1.9M in total, which decreased by 28% compared to 2018. 52% of Basta's compensation, or $974K, was in stock awards. Basta also received $306K in bonus and $598K in salary.
Kristine Ball, Chief Financial Officer, received a compensation package of $898K, which decreased by 29% compared to previous year. 46% of the compensation package, or $416K, was in salary.
Paul Kwon, Chief Scientific Officer, earned $893K in 2019.
Related executives
You may also like
Source: SEC filing on June 22, 2020.